GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,233,463 | +7.6% | 165,830 | +29.0% | 0.00% | 0.0% |
| Q2 2023 | $7,654,168 | -68.2% | 128,555 | -69.8% | 0.00% | -60.0% |
| Q1 2023 | $24,104,741 | +88.8% | 425,578 | +147.5% | 0.01% | +66.7% |
| Q4 2022 | $12,769,097 | +13.7% | 171,928 | -8.8% | 0.00% | 0.0% |
| Q3 2022 | $11,226,000 | -1.6% | 188,463 | -7.3% | 0.00% | 0.0% |
| Q2 2022 | $11,408,000 | -22.0% | 203,217 | +2.5% | 0.00% | 0.0% |
| Q1 2022 | $14,627,000 | +32.0% | 198,238 | +29.2% | 0.00% | +50.0% |
| Q4 2021 | $11,080,000 | -43.8% | 153,459 | -40.4% | 0.00% | -50.0% |
| Q3 2021 | $19,722,000 | -16.2% | 257,401 | -15.2% | 0.00% | -20.0% |
| Q2 2021 | $23,532,000 | +102.6% | 303,515 | +61.1% | 0.01% | +66.7% |
| Q1 2021 | $11,617,000 | -36.2% | 188,355 | -32.6% | 0.00% | -40.0% |
| Q4 2020 | $18,220,000 | -48.9% | 279,344 | -61.2% | 0.01% | -50.0% |
| Q3 2020 | $35,642,000 | -15.1% | 719,727 | -18.2% | 0.01% | -23.1% |
| Q2 2020 | $41,988,000 | +5.8% | 880,080 | -5.6% | 0.01% | -7.1% |
| Q1 2020 | $39,669,000 | +55.0% | 932,717 | +114.6% | 0.01% | +100.0% |
| Q4 2019 | $25,591,000 | +84.0% | 434,622 | +59.8% | 0.01% | +75.0% |
| Q3 2019 | $13,908,000 | -4.2% | 272,063 | -20.7% | 0.00% | 0.0% |
| Q2 2019 | $14,513,000 | -40.5% | 343,099 | -30.5% | 0.00% | -42.9% |
| Q1 2019 | $24,383,000 | +1.6% | 493,490 | -11.0% | 0.01% | -12.5% |
| Q4 2018 | $23,995,000 | -19.9% | 554,412 | +5.1% | 0.01% | 0.0% |
| Q3 2018 | $29,953,000 | +13.1% | 527,707 | +0.5% | 0.01% | +14.3% |
| Q2 2018 | $26,493,000 | -18.2% | 525,045 | -19.2% | 0.01% | -12.5% |
| Q1 2018 | $32,392,000 | +106.7% | 650,183 | +70.6% | 0.01% | +100.0% |
| Q4 2017 | $15,668,000 | +62.6% | 381,218 | +17.6% | 0.00% | +100.0% |
| Q3 2017 | $9,638,000 | +75.1% | 324,256 | +95.2% | 0.00% | +100.0% |
| Q2 2017 | $5,505,000 | +41.3% | 166,090 | +26.2% | 0.00% | 0.0% |
| Q1 2017 | $3,897,000 | -17.7% | 131,577 | -31.1% | 0.00% | 0.0% |
| Q4 2016 | $4,737,000 | +1.7% | 190,930 | -7.4% | 0.00% | 0.0% |
| Q3 2016 | $4,656,000 | +0.2% | 206,250 | +5.8% | 0.00% | -50.0% |
| Q2 2016 | $4,646,000 | -42.4% | 194,940 | -42.6% | 0.00% | 0.0% |
| Q1 2016 | $8,068,000 | +78.7% | 339,683 | +109.4% | 0.00% | +100.0% |
| Q4 2015 | $4,514,000 | +267.9% | 162,232 | +173.3% | 0.00% | – |
| Q3 2015 | $1,227,000 | +114.1% | 59,363 | +166.3% | 0.00% | – |
| Q2 2015 | $573,000 | -26.1% | 22,294 | -27.4% | 0.00% | – |
| Q1 2015 | $775,000 | +127.3% | 30,690 | +114.0% | 0.00% | – |
| Q4 2014 | $341,000 | -23.0% | 14,338 | -36.3% | 0.00% | – |
| Q3 2014 | $443,000 | -47.4% | 22,511 | -36.1% | 0.00% | – |
| Q2 2014 | $842,000 | +16.8% | 35,213 | +29.8% | 0.00% | – |
| Q1 2014 | $721,000 | -96.1% | 27,132 | -97.0% | 0.00% | -100.0% |
| Q4 2013 | $18,430,000 | -84.5% | 913,292 | -86.6% | 0.01% | -86.4% |
| Q3 2013 | $119,171,000 | -9.5% | 6,825,337 | -12.6% | 0.04% | -13.7% |
| Q2 2013 | $131,732,000 | +64.1% | 7,813,261 | +2.1% | 0.05% | +54.5% |
| Q4 2012 | $80,289,000 | -41.7% | 7,653,897 | +0.1% | 0.03% | -40.0% |
| Q3 2012 | $137,830,000 | – | 7,644,526 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |